VIDEO: Development of JAK inhibitors for atopic dermatitis

Editor’s note: This is a previously posted video, and the below is an automatically generated transcript to be used for informational purposes. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Yeah, so some of the most recent advancements in atopic dermatitis treatment are the development and implementation of JAK inhibitors for atopic dermatitis. So we have both oral and topical JAK inhibitors that we can use for difficult to treat atopic dermatitis. So some of the oral medications include Abrocitinib and upadacitinib, and the topical medications include ruxolitinib. Ruxolitinib deserves special note because it's also the only FDA approved treatment for repigmentation in vitiligo. So many patients I have used both Ruxolitinib in treatment of their atopic dermatitis and their vitiligo.